Koninklijke Philips N.V.: Business Overview, Financials & Competitive Analysis
Koninklijke Philips N.V. scores 7/10 on the AskCyborg Cyborg Score (Strong). Philips benefits from sector-wide valuation tailwinds, anticipated MedTech revival in 2026, and accelerating organic revenue growth. Philips reported Street-beating Q4 2025 results and forecast 3–4.5% comparable sales growth in 2026. Recent profitability metrics show net margin of 5.09% and return on equity of 13.68%. However, the Altman Z-Score of.
What is Koninklijke Philips N.V.'s industry? Koninklijke Philips N.V. (philips.com) operates in Medical Devices & Healthcare Technology. AskCyborg classifies Koninklijke Philips N.V. under Medical Devices & Healthcare Technology in its company registry.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis an...
Cyborg Score thesis
Philips benefits from sector-wide valuation tailwinds, anticipated MedTech revival in 2026, and accelerating organic revenue...
Read the full analyst-debate transcript →Get the Latest Koninklijke Philips N.V. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeKoninklijke Philips N.V. Overview
Pro stress-test →Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment featuring imaging systems, ultrasound equipment, and image-guided therapy solutions; connected care (under 30%) encompasses monitoring and analytics systems; and personal health includes electric toothbrushes and personal-care products. The company is a leading medtech player with strong innovation capabilities.
Strategic Profile
Pro stress-test →Philips was named a Clarivate Top 100 Global Innovator for 2026 on its 13th consecutive year, with more than EUR 1.7 billion in annual R&D investment (about 9% of sales). The company targets mid-single-digit comparable sales growth CAGR through 2028 and mid-teens adjusted EBITA margin in 2028.
Competitive Landscape
Pro stress-test →ResMed, Baxter International, Terumo, and Siemens Healthineers are competitors of Philips. Philips differentiates through breadth across diagnostics, treatment, connected care, and personal health segments, strong R&D investment, and AI-enabled innovation in medical imaging.
Industry Context
Koninklijke Philips N.V. operates in Medical Devices & Healthcare Technology.
Key facts
Founded: 1891 · Headquarters: Amsterdam, Netherlands · Employees: 64,817 · Revenue: $19.84B · Market cap: $30.77B